- Home
- FENC vs RAAQ Comparison
FENC vs RAAQ Comparison
Compare FENC & RAAQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$5.86
Company Overview
Basic Information| Metric | FENC | RAAQ |
|---|---|---|
| Founded | 1996 | 2024 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 266.4M | 239.2M |
| IPO Year | 2010 | N/A |
Fundamental Metrics
Financial Performance| Metric | FENC | RAAQ |
|---|---|---|
| Price | $5.86 | $10.41 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $15.00 | N/A |
| AVG Volume (30 Days) | ★ 206.5K | 52.9K |
| Earning Date | 05-12-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $44,642,000.00 | N/A |
| Revenue This Year | $69.68 | N/A |
| Revenue Next Year | $37.30 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $4.98 | $9.62 |
| 52 Week High | $9.92 | $10.80 |
Technical Indicators
Market Signals| Indicator | FENC | RAAQ |
|---|---|---|
| Relative Strength Index (RSI) | 34.75 | 44.30 |
| Support Level | $5.65 | $10.25 |
| Resistance Level | $9.16 | $10.48 |
| Average True Range (ATR) | 0.44 | 0.09 |
| MACD | 0.00 | -0.02 |
| Stochastic Oscillator | 10.70 | 11.11 |
Price Performance
Historical Comparison FENC
RAAQ
About FENC Fennec Pharmaceuticals Inc.
Fennec Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. Its product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin-induced hearing loss, or ototoxicity in children. The company principally operates in the United States.
About RAAQ Real Asset Acquisition Corp. Class A Ordinary Share
Real Asset Acquisition Corp is a blank check company.